EUVIMEDEUVIMED entdecken
Open Access

Isolation and genome characterization of SARS-CoV-2 recombinant Omicron variant XBB.1.16 from Central India

Rohit Menon, Sushil Kumar Sharma iD, Anshuman Behera, Ambuj Shrivastava, Shashi Sharma, Jyoti S Kumar, Paban Kumar Dash, Manmohan Parida

VirusDisease · 2026-09 · 37 (3) · 296-303

DOI: 10.1007/s13337-026-00974-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift VirusDisease, online erschienen am 22.07.2026. Verfasst von Rohit Menon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Virology, Defence Research & Development Establishment (DRDE), Jhansi Road, Gwalior, 474002 India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: defence research and development organisation, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the World Health Organization's declaration in May 2023 of the end of the Public Health Emergency of International Concern (PHEIC), COVID-19 continues to circulate globally. As such, the continued transmission across the different parts of the globe resulted in the emergence of variants which could pose a constant challenge to public health. The isolation of circulating virus variants during these times is essential to assess the impact of the strains and establish effective counter-measures if necessary. This study focuses on the isolation and characterization of the SARS-CoV-2 recombinant Omicron variant XBB.1.16 from a clinical sample in Central India, collected during an early 2023 surge. Using a throat swab, confirmation of the variant by qRT-PCR and distinctive Cytopathic Effects (CPE) were observed on the Vero E6 cell line. The isolation by passages of the virus was found to be successful through positive qRT-PCR and next-generation sequencing (NGS). The isolate was found to be XBB.1.16, Clade GRA, a Variant of Interest (VOI) after sequencing. Detailed analysis of the spike gene indicated 53 mutations leading to 45 amino acid substitutions compared to the original Wuhan strain. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s13337-026-00974-w.

Schlagwörter

Stichwörter der Autor:innen

Cytopathic effectGenome analysisIsolationSARS-CoV-2Sequencing

Autor:innen und Institutionen

  • Division of Virology, Defence Research & Development Establishment (DRDE), Jhansi Road, Gwalior, 474002 India.

ORCID-Profile: Sushil Kumar Sharma

Förderung

  • defence research and development organisation, India

Zitieren

APA

Menon, R., Sharma, S. K., Behera, A., Shrivastava, A., Sharma, S., Kumar, J. S., Dash, P. K., & Parida, M. (2026). Isolation and genome characterization of SARS-CoV-2 recombinant Omicron variant XBB.1.16 from Central India. VirusDisease, 37(3), 296-303. https://doi.org/10.1007/s13337-026-00974-w

Vancouver

Menon R, Sharma SK, Behera A, Shrivastava A, Sharma S, Kumar JS, et al. Isolation and genome characterization of SARS-CoV-2 recombinant Omicron variant XBB.1.16 from Central India. VirusDisease. 2026;37(3):296-303. doi:10.1007/s13337-026-00974-w

BibTeX
@article{Menon2026,
  author = {Menon, Rohit and Sharma, Sushil Kumar and Behera, Anshuman and Shrivastava, Ambuj and Sharma, Shashi and Kumar, Jyoti S and Dash, Paban Kumar and Parida, Manmohan},
  title = {Isolation and genome characterization of SARS-CoV-2 recombinant Omicron variant XBB.1.16 from Central India},
  journal = {VirusDisease},
  year = {2026},
  volume = {37},
  number = {3},
  pages = {296--303},
  doi = {10.1007/s13337-026-00974-w}
}
Kostenlos starten →